Effects of corticosteroids on HCV infection

The risk factors for clinical recurrent hepatitis C in liver transplant recipients are not clearly defined. It has been suggested that the corticosteroids included in the treatments of patients undergoing allograft rejection might induce acute hepatitis by increasing HCV replication. In this study w...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of immunopharmacology Vol. 21; no. 4; pp. 253 - 261
Main Authors Magy, N, Cribier, B, Schmitt, C, Ellero, B, Jaeck, D, Boudjema, K, Wolf, P, Labouret, N, Doffoel, M, Kirn, A, Stoll-Keller, F
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Science 01.04.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The risk factors for clinical recurrent hepatitis C in liver transplant recipients are not clearly defined. It has been suggested that the corticosteroids included in the treatments of patients undergoing allograft rejection might induce acute hepatitis by increasing HCV replication. In this study we investigated the effects of corticosteroid boluses on HCV viremia in liver allograft recipients treated for acute rejection. Since we had previously developed a model of HCV replication in peripheral blood mononuclear cells (PBMC) in vitro, we also studied the effects of corticosteroids on HCV replication in vitro. A transient peak of HCV viremia was observed in patients treated with corticosteroid boluses for an acute allograft rejection. In the cell cultures, corticosteroids induced an increase of the total amount of viral RNA detectable. Our results demonstrate that corticosteroids induce an increase of hepatitis C virus replication in vivo and in vitro.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0192-0561
1879-3495
DOI:10.1016/S0192-0561(99)00005-3